Mark C. Wiggins's most recent trade in TRACON Pharmaceuticals Inc was a trade of 80,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 28, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TRACON Pharmaceuticals Inc | Mark C. Wiggins | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 80,000 | 80,000 | - | - | Employee Stock Option (Right to Buy) |